B.I. Gataullin1,2, I.G. Gataullin1, R.G. Biktemirova2
1Kazan State Medical Academy ― Branch Campus of the FSBEI FPE RMACPE MOH Russia, Kazan
2Kazan (Volga Region) Federal University, Institute of Fundamental Medicine and Biology, Kazan
Gataullin Bulat I. ― Cand. of Sci. (Med.), Associate Professor of the Department of Surgery at the Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University
76 Karl Marx Str., Kazan, 420012, Russian Federation, tel. +7-962-553-31-07, e-mail: bulatg@list.ru, ORCID ID: 0000-0003-1695-168X
Abstract. In recent years, the BRICS countries have been experiencing a dynamic socio-economic transformation and an era of urbanization. By eradicating infectious diseases, the BRICS countries are also spreading the spread of aging and non-communicable diseases in order to increase the decline in life expectancy and change lifestyles. Each BRICS country has its own characteristics of morbidity, quality of health care, development of screening of the main localizations, etc.
The aim of this study is a comparative analysis of the oncological situation in the BRICS countries, identification of opportunities and conditions for international member countries of the alliance to develop a joint strategy for cooperation in the field of oncology.
The authors conducted a literature review to analyze the state and problems of BRICS cooperation in the field of health care for further scientific research on the problems of morbidity and mortality of the population in malignant neoplasms. When analyzing the data presented on the website of the International Agency for Research on Cancer (IARC), it was revealed that malignant neoplasms (MNO) pose a serious problem for the BRICS countries, since 38% of newly diagnosed cases and 42% of deaths from cancer worldwide are constantly in these countries. The BRICS countries are characterized by high oncological morbidity and mortality.
Conclusion. Today, there are many problems that create a standard protocol for solving the problems facing healthcare in these countries due to different financing, different structure of morbidity, system of higher and postgraduate education, availability of medical care, differences in organizational gradualness of healthcare management, etc. Further scientific research on the problems of morbidity and mortality in malignant neoplasms is needed to develop a joint strategy for combating cancer in the BRICS countries.
Key words: BRICS countries, malignant neoplasms, morbidity, mortality.